Skip to main content
Thorax logoLink to Thorax
. 1993 May;48(5):558–559. doi: 10.1136/thx.48.5.558

Central venous catheter associated thrombosis of major veins: thrombolytic treatment with recombinant tissue plasminogen activator.

S Rodenhuis 1, L G van't Hek 1, L T Vlasveld 1, R Kröger 1, R Dubbelman 1, R G van Tol 1
PMCID: PMC464517  PMID: 8322245

Abstract

OBJECTIVE--Major thromboses can occur in the venous system in association with central venous catheters. This usually necessitates removal of the catheter. METHODS--The effectiveness of low dose recombinant tissue type plasminogen activator (rt-PA) in combination with heparin was assessed in patients with central venous catheter associated thrombosis. RESULTS--In five patients, all suffering from cancer, a 5-7 day continuous infusion resulted in complete lysis of the thrombus without complications in three. In the other two patients moderately severe haemorrhage was observed with only partial lysis, of the thrombus. CONCLUSIONS--The infusion of heparin and rt-PA is potentially effective in thrombosis related to use of central venous catheters, but the risk of haemorrhage is not inconsiderable.

Full text

PDF
558

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertrand M., Presant C. A., Klein L., Scott E. Iatrogenic superior vena cava syndrome. A new entity. Cancer. 1984 Jul 15;54(2):376–378. doi: 10.1002/1097-0142(19840715)54:2<376::aid-cncr2820540235>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  2. Gray B. H., Olin J. W., Graor R. A., Young J. R., Bartholomew J. R., Ruschhaupt W. F. Safety and efficacy of thrombolytic therapy for superior vena cava syndrome. Chest. 1991 Jan;99(1):54–59. doi: 10.1378/chest.99.1.54. [DOI] [PubMed] [Google Scholar]
  3. Greenberg S., Kosinski R., Daniels J. Treatment of superior vena cava thrombosis with recombinant tissue type plasminogen activator. Chest. 1991 May;99(5):1298–1301. doi: 10.1378/chest.99.5.1298. [DOI] [PubMed] [Google Scholar]
  4. Katz P. O., Hackshaw B. T., Barish C. F., Powell B. L. Venous thrombosis as a cause of superior vena cava syndrome. Rapid response to streptokinase. Arch Intern Med. 1983 May;143(5):1050–1052. [PubMed] [Google Scholar]
  5. Runge M. S., Quertermous T., Haber E. Plasminogen activators. The old and the new. Circulation. 1989 Feb;79(2):217–224. doi: 10.1161/01.cir.79.2.217. [DOI] [PubMed] [Google Scholar]
  6. Sculier J. P., Feld R. Superior vena cava obstruction syndrome: recommendations for management. Cancer Treat Rev. 1985 Sep;12(3):209–218. doi: 10.1016/0305-7372(85)90038-6. [DOI] [PubMed] [Google Scholar]
  7. Stewart A., Mayne E. E. Rapid resolution of subclavian vein thrombosis by tissue plasminogen activator. Lancet. 1988 Apr 16;1(8590):890–890. doi: 10.1016/s0140-6736(88)91644-3. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES